In the first quarter of 2026, Ozon Pharma recorded net profit of 1.3…
In the first quarter of 2026, Ozon Pharma recorded net profit of 1.3 billion rubles according to IFRS. Net profit increased by 30% in Q1 2026 compared to the same period in 2025, reaching 1.3 billion rubles.
Consensus
- Shareholders of OZON Pharmaceuticals approved dividends of 0.27 rubles per share for Q1 2026
- The total amount allocated for dividends is 315.28 million rubles
- Net profit for Q1 2026 was 1.3 billion rubles
- The debt-to-EBITDA ratio was 0.6x
- Dividends will be paid to shareholders who are registered by July 8
Points of divergence
- The total amount allocated for dividends is 315.27 million rubles — kommersant
- Net profit for Q1 2026 was 1.3 billion rubles — vedomosti
- Dividend yield is 0.67% — kommersant
- Net profit for 2025 was 2.3 billion rubles — vedomosti
- Revenue for Q1 2026 was 7 billion rubles — vedomosti
- Adjusted EBITDA for Q1 2026 was 2.5 billion rubles — vedomosti
- The company forecasts revenue growth of 15-25% for 2026 — vedomosti
Coverage (2 sources)
- Ozon Pharma will pay dividends for the first quarter of 2026 — Коммерсантъ
- Ozon Pharma shareholders approved dividends for Q1 — Ведомости